Lineage Cell Therapeutics...

AI Score

0

Unlock

0.57
0.02 (3.64%)
At close: Jan 15, 2025, 9:56 AM

Lineage Cell Therapeutics Inc. Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for LCTX stock have an median target of 4, with a low estimate of 2 and a high estimate of 9. The median target predicts an increase of 601.75% from the current stock price of 0.57.

Analyst Consensus: Buy
Target Low Average Median High
Price $2 $4.8 $4 $9
Change 250.88% 742.11% 601.75% 1478.95%

AI Analyst Report

D. Boral Capital has upheld a Buy rating on Lineag... Unlock content with Pro Subscription

Updated Jan 03, 2025

Rating Mar 24May 24Aug 24Nov 24Dec 24Jan 25
Strong Buy 000010
Buy 111202
Hold 000000
Sell 000000
Strong Sell 000000
Total 1 1 1 2 1 2

Financial Forecast this Year

Revenue This Year
8.18M
from 8.95M
Increased by -8.6%
Revenue Next Year
11.59M
from 8.18M
Increased by 41.8%
EPS This Year
-0.05
from -0.12
Increased by 58.3%
EPS Next Year
-0.1
from -0.05
Increased by -100%